Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Edward Russell, René Lenggenhager, and more

Edward Russell

Edward Russell has joined Quidel in the newly created role of senior vice president, global commercial operations, the company said in a document filed with the US Securities and Exchange Commission. The position will consolidate Quidel's commercial functions under one global commercial umbrella, the firm said. Russell was previously with Thermo Fisher Scientific, and before that, he was with Life Technologies, which was acquired by Thermo Fisher. At Life Tech he had various leadership roles, including North America commercial leader of the BioSciences Division, and president of Life Technologies Japan. He also has held leadership positions at FedEx Kinko's, ExxonMobil, and Toyota/Lexus. 

René Lenggenhager 

Bruker announced the appointment of René Lenggenhager as president of the Bruker BioSpin Group, effective Nov. 1. He has more than 25 years of management experience in international high-tech companies and in the scientific instruments industry. Since 2004, Lenggenhager has been general manager for Laboratory Weighing at Mettler Toledo. Before that, he was head of R&D of Laboratory and Weighing Technologies at the Mettler Toledo. Previously, he was at Siemens Building Technologies SBT Cerberus Division; at Cerberus; at Landis & Gyr; and at Metrohm. 

Tina Nova, Craig Johnson 

GenomeDx Biosciences has appointed Tina Nova and Craig Johnson to its board of directors. Nova co-founded the molecular diagnostics company Genoptix in 2000 and served as president, CEO, and director until its acquisition by Novartis in 2011. Prior to that, Nova co-founded Nanogen, where she served as president and chief operations officer. Johnson is currently director for Mirati Therapeutics, La Jolla Pharmaceutical Company, and Theron Therapeutics. He has also served as chief financial officer at NovaDel Pharma, TorreyPines Therapeutics, and MitoKor. 

Steve Arlington

Steve Arlington has been appointed the president of the Pistoia Alliance. He was previously the global lead partner, pharmaceuticals and life sciences consulting at PwC. He began his research career at Smith Kline and has held senior roles at Unipath, PA Consulting, and IBM. Arlington replaces Michael Braxenthaler. 

For more recent items on executive appointments and promotions in the omics and molecular diagnostics industries, please see the People in the News page on our website.